University Hospital Tuebingen
Clinical trials sponsored by University Hospital Tuebingen, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Plasma zaps HPV: new hope for cervical infections? Results expected Sep 2026 (estimated)
- App helps track health of preterm babies as they grow Results expected Dec 2026 (estimated)
- New Virus-Based COVID booster enters human trials Results expected Dec 2026 (estimated)
- Pen and paper power: journaling may supercharge psychotherapy Results expected Dec 2026 (estimated)
- Fasting fix? new study tests 4-Week diet to boost insulin in prediabetes and diabetes Results expected Dec 2026 (estimated)
-
Eye stroke treatment put to the test: can clot busters save sight?
Disease control Stopped earlyThis study tested whether giving a clot-busting drug (tenecteplase or alteplase) within 4.5 hours of an eye stroke could restore vision. Eye stroke, or central retinal artery occlusion, is a blockage in the eye's main artery that often causes permanent vision loss. The trial aime…
Phase 3 • Sponsor: University Hospital Tuebingen • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Could a simple switch in catheters prevent post-stroke delirium?
Knowledge-focused Stopped earlyThis study looked at whether using a condom catheter instead of a standard indwelling urinary catheter (IUC) lowers the chance of delirium in men aged 70+ who had a stroke. Delirium is a sudden confused state that can happen after a stroke. The trial planned to compare two groups…
Sponsor: University Hospital Tuebingen • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC